Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tela Bio Inc
(NQ:
TELA
)
2.870
+0.110 (+3.99%)
Streaming Delayed Price
Updated: 11:11 AM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Tela Bio Inc
< Previous
1
2
Next >
TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance
August 12, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
July 25, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Second Quarter 2024 Financial Results
July 22, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
June 04, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
May 20, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports First Quarter 2024 Financial Results
May 09, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce First Quarter 2024 Financial Results
April 25, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
April 15, 2024
Targets the more than 665,000 inguinal hernia procedures performed annually in the United States (U.S.)
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
April 08, 2024
Howard N. Langstein, MD, FACS joins innovative MedTech company to leverage his vast experience to help other surgeons optimize clinical outcomes in plastic and reconstructive surgery
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
March 21, 2024
Strong and secure, LIQUIFIX is the first approved adhesive-based product to affix mesh without penetrating patient tissue
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
March 20, 2024
TELA Bio to receive at least $8 million and up to $12 million in total consideration
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
February 29, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 23, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 19, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 15, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Take Part in Connecting the Dots
December 05, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
November 16, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 10, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports Third Quarter 2023 Financial Results
November 09, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Third Quarter 2023 Financial Results
October 26, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
September 18, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
August 16, 2023
New addition expands reconstruction options for surgeons and patients
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports Second Quarter 2023 Financial Results
August 09, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the Jefferies Global Healthcare Conference
May 25, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab
May 19, 2023
Company prioritizes education with a variety of in-person and virtual training programs
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports First Quarter 2023 Financial Results
May 11, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.